| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |